SLSN
Solesence·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About SLSN
Solesence, Inc.
A leader in science driven healthcare solutions across beauty and life science categories
Healthcare Providers and Services
11/25/1989
04/08/2025
NASDAQ Stock Exchange
98
12-31
Common stock
1319 Marquette Drive, Romeoville, Illinois 60446
--
Solesence, Inc., was incorporated in Illinois on November 25, 1989 and became a Delaware corporation during November 1997. Solesence is a leader in science-driven health care solutions across the beauty and life sciences categories. Solesence Primary Skin Care Products is a fully developed prestige skin care formulation with mineral-based UV protection, made possible by its proprietary active pharmaceutical ingredients, which are also sold as APIs to manufacturers of other types of skin care products, including sunscreen and daily care products.
Earnings Call
Q3/2025
Estimate EPS--
Actual EPS-0.02
Estimate Revenue--
Actual Revenue14.60M
Solesence's Q3 2025 Earnings Call: Clashing Growth Projections, Revenue Forecasts, and Margin Recovery Optimism
Nov 11,2025 11:50
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
SLSN has released its 2025 Q3 earnings. EPS was reported at -0.02, versus the expected 0, missing expectations. The chart below visualizes how SLSN has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
SLSN has released its 2025 Q3 earnings report, with revenue of 14.60M, reflecting a YoY change of -13.45%, and net profit of -1.12M, showing a YoY change of -136.78%. The Sankey diagram below clearly presents SLSN's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
